Free Trial

National Vision (EYE) Competitors

National Vision logo
$16.68 +0.35 (+2.14%)
Closing price 04:00 PM Eastern
Extended Trading
$16.63 -0.05 (-0.29%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EYE vs. NVST, STVN, LQDA, LIVN, and IRTC

Should you buy National Vision stock or one of its competitors? MarketBeat compares National Vision with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with National Vision include Envista (NVST), Stevanato Group (STVN), Liquidia (LQDA), LivaNova (LIVN), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.

How does National Vision compare to Envista?

Envista (NYSE:NVST) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

Envista has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, National Vision has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market.

Envista has higher revenue and earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.72B1.34$47M$0.4154.60
National Vision$1.99B0.67$29.60M$0.5729.26

In the previous week, National Vision had 5 more articles in the media than Envista. MarketBeat recorded 5 mentions for National Vision and 0 mentions for Envista. National Vision's average media sentiment score of 1.18 beat Envista's score of 1.00 indicating that National Vision is being referred to more favorably in the news media.

Company Overall Sentiment
Envista Positive
National Vision Positive

Envista currently has a consensus target price of $28.83, indicating a potential upside of 28.81%. National Vision has a consensus target price of $30.08, indicating a potential upside of 80.36%. Given National Vision's stronger consensus rating and higher possible upside, analysts plainly believe National Vision is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.40
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58

Envista has a net margin of 2.41% compared to National Vision's net margin of 2.31%. Envista's return on equity of 7.11% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
National Vision 2.31%6.41%2.81%

Summary

Envista and National Vision tied by winning 7 of the 14 factors compared between the two stocks.

How does National Vision compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

Stevanato Group has a net margin of 11.76% compared to National Vision's net margin of 2.31%. Stevanato Group's return on equity of 10.27% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group11.76% 10.27% 6.08%
National Vision 2.31%6.41%2.81%

Stevanato Group has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group€1.34B4.20€158.21M€0.5931.53
National Vision$1.99B0.67$29.60M$0.5729.26

In the previous week, Stevanato Group had 1 more articles in the media than National Vision. MarketBeat recorded 6 mentions for Stevanato Group and 5 mentions for National Vision. National Vision's average media sentiment score of 1.18 beat Stevanato Group's score of 0.80 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision has a consensus price target of $30.08, suggesting a potential upside of 80.36%. Given National Vision's higher probable upside, analysts clearly believe National Vision is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58

Stevanato Group has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, National Vision has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market.

Summary

Stevanato Group beats National Vision on 10 of the 15 factors compared between the two stocks.

How does National Vision compare to Liquidia?

Liquidia (NASDAQ:LQDA) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

National Vision has higher revenue and earnings than Liquidia. National Vision is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liquidia$158.32M31.19-$68.92M$0.14396.64
National Vision$1.99B0.67$29.60M$0.5729.26

64.5% of Liquidia shares are owned by institutional investors. 25.6% of Liquidia shares are owned by insiders. Comparatively, 2.4% of National Vision shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Liquidia has a net margin of 7.74% compared to National Vision's net margin of 2.31%. Liquidia's return on equity of 46.82% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Liquidia7.74% 46.82% 7.06%
National Vision 2.31%6.41%2.81%

Liquidia currently has a consensus target price of $50.88, indicating a potential downside of 8.38%. National Vision has a consensus target price of $30.08, indicating a potential upside of 80.36%. Given National Vision's higher probable upside, analysts clearly believe National Vision is more favorable than Liquidia.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Liquidia
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
3 Strong Buy rating(s)
2.91
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58

Liquidia has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market. Comparatively, National Vision has a beta of 1.07, suggesting that its share price is 7% more volatile than the broader market.

In the previous week, Liquidia had 3 more articles in the media than National Vision. MarketBeat recorded 8 mentions for Liquidia and 5 mentions for National Vision. National Vision's average media sentiment score of 1.18 beat Liquidia's score of 0.75 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Liquidia
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Liquidia beats National Vision on 10 of the 17 factors compared between the two stocks.

How does National Vision compare to LivaNova?

LivaNova (NASDAQ:LIVN) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation, dividends and media sentiment.

In the previous week, National Vision had 3 more articles in the media than LivaNova. MarketBeat recorded 5 mentions for National Vision and 2 mentions for LivaNova. National Vision's average media sentiment score of 1.18 beat LivaNova's score of 0.58 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision has higher revenue and earnings than LivaNova. National Vision is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.39B2.82-$242.47M$1.9536.56
National Vision$1.99B0.67$29.60M$0.5729.26

LivaNova presently has a consensus target price of $79.38, suggesting a potential upside of 11.35%. National Vision has a consensus target price of $30.08, suggesting a potential upside of 80.36%. Given National Vision's higher probable upside, analysts clearly believe National Vision is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.67
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58

LivaNova has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, National Vision has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market.

LivaNova has a net margin of 7.48% compared to National Vision's net margin of 2.31%. LivaNova's return on equity of 16.48% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova7.48% 16.48% 7.59%
National Vision 2.31%6.41%2.81%

97.6% of LivaNova shares are held by institutional investors. 0.4% of LivaNova shares are held by insiders. Comparatively, 2.4% of National Vision shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

LivaNova and National Vision tied by winning 8 of the 16 factors compared between the two stocks.

How does National Vision compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and National Vision (NASDAQ:EYE) are both medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

National Vision has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$747.14M4.60-$44.55M-$0.86N/A
National Vision$1.99B0.67$29.60M$0.5729.26

In the previous week, iRhythm Technologies and iRhythm Technologies both had 5 articles in the media. National Vision's average media sentiment score of 1.18 beat iRhythm Technologies' score of 0.79 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

iRhythm Technologies has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, National Vision has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market.

iRhythm Technologies presently has a consensus price target of $189.69, suggesting a potential upside of 81.42%. National Vision has a consensus price target of $30.08, suggesting a potential upside of 80.36%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities research analysts plainly believe iRhythm Technologies is more favorable than National Vision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94
National Vision
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58

National Vision has a net margin of 2.31% compared to iRhythm Technologies' net margin of -3.53%. National Vision's return on equity of 6.41% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-3.53% -10.26% -1.39%
National Vision 2.31%6.41%2.81%

Summary

National Vision beats iRhythm Technologies on 8 of the 14 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionCONS PD IndustryStaples SectorNASDAQ Exchange
Market Cap$1.31B$30.29B$15.89B$12.54B
Dividend YieldN/A3.49%3.55%5.22%
P/E Ratio29.2669.7625.5524.18
Price / Sales0.671.4947.58112.26
Price / Cash9.1234.5216.9657.13
Price / Book1.5210.305.506.72
Net Income$29.60M$1.33B$673.38M$337.19M
7 Day Performance0.54%1.71%-1.22%0.48%
1 Month Performance-29.14%-0.86%-3.04%5.07%
1 Year Performance-21.76%-18.79%-12.82%34.25%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
4.6983 of 5 stars
$16.68
+2.1%
$30.08
+80.4%
-22.9%$1.31B$1.99B29.2613,138
NVST
Envista
3.4405 of 5 stars
$24.05
+2.6%
$28.83
+19.9%
+26.6%$3.91B$2.72B58.6612,000
STVN
Stevanato Group
2.6114 of 5 stars
€18.12
+0.6%
N/A-14.0%€5.49B€1.34B30.726,010
LQDA
Liquidia
2.5053 of 5 stars
$61.01
+0.0%
$49.33
-19.1%
+226.7%$5.43B$158.32M435.8250
LIVN
LivaNova
3.0252 of 5 stars
$73.83
flat
$79.38
+7.5%
+68.9%$4.06B$1.39B37.863,300

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners